Please assess the completion status of the following clinical trial:

Trial Title: GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV negative as determined by concordant rapid testing~* HSV-2 seropositive (Focus HerpeSelect \>3.4)~* At least one prior occurrence of GUD~* 18-50 years of age~Exclusion Criteria:~* Current use, or use w/in past 7 days of acyclovir, valacyclovir, or famciclovir~* Prior hypersensitivity \&/or allergic reaction to acyclovir~* Use of probenicid~* Current use, or use within past 28 days, of an investigational agent~* Currently pregnant or nursing~* Currently plan to become pregnant during next 3 months~* Any condition that will interfere with successful completion of study procedures

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- acyclovir (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).